Market Exclusive

Nu Skin Enterprises, Inc. (NYSE:NUS) reported earnings of $0.95 per share beating Walls Streets expectations.

Nu Skin Enterprises, Inc. (NYSE:NUS) reported Q2 2018 earnings this Afternoon, coming in at $0.95 per share, beating Wall Street’s estimates of $0.92 per Share. Revenue for the quarter came in at $704.19 million beating analyst estimates of $642.16 million Recent Insider Trading for Nu Skin Enterprises, Inc. (NYSE:NUS)

Dividend History for Nu Skin Enterprises, Inc. (NYSE:NUS)

About Company Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Recent Analyst Rating for Nu Skin Enterprises, Inc. (NYSE:NUS)